Back to Results
First PageMeta Content
Medical genetics / Genetic testing / Pharmacology / United States Public Health Service / Science and Technology Options Assessment / Medical device / Food and Drug Administration / Predictive medicine / Direct-to-consumer advertising / Medicine / Health / Medical ethics


  Direct‐to‐Consumer Genetic Testing for Health‐Related Purposes in the  European Union    Summary of points from a meeting organised by EASAC, FEAM and STOA in the  European Parliament 
Add to Reading List

Document Date: 2013-01-25 04:17:26

Open Document

File Size: 445,04 KB

Share Result on Facebook

City

Amsterdam / /

Company

STOA / /

Continent

Europe / /

Facility

University of Leuven / Karlsruhe Institute of Technology / VU University Medical Center / /

IndustryTerm

medical insurance / genetic testing services / public health systems / in vitro diagnostic medical devices / public medical genetic services / data bank / pharmaceutical regulation / medical genetic services / public health services / technology assessment / diagnostic medical devices / /

MedicalCondition

high penetrance serious disorders / disease / common / complex disorders / gene‐disease associations / relatively rare inherited disorders / /

Organization

Panel / VU University Medical Center / European Medicines Agency / European Academies Science Advisory Council / Federation of European Academies of Medicine / Institute of Technology / University of Leuven / European Commission / FDA / Committee on Bioethics / European Union / European Parliament / Council of Europe / /

Person

Pascal Borry / Antonio Correia de Campos / Anne Forus / Sabine Lecrenier / Leonhard Hennen / Martina Cornel / /

Position

Chairman / Professor / physician / /

Technology

genomics / human genome / /

URL

http /

SocialTag